Physician profile

Michael E Johnson

Orthopaedic Surgery · Greenville, TX

NPI 1053593244

$3,305.97

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$160.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $3,011.67 2019-2022
Zimmer Biomet Holdings, INC. $137.13 2023 Persona, Rosa
Depuy Synthes Sales INC. $45.08 2020-2021
Fx Shoulder Solutions, INC $24.52 2019
Pacira Pharmaceuticals Incorporated $23.42 2023 Exparel, Iovera, Zilretta
Bioventus LLC $21.42 2019
Boston Scientific Corporation $17.45 2019
Novartis Pharmaceuticals Corporation $12.79 2019
Horizon Therapeutics Plc $12.49 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael E Johnson

$3,305.97

in general payments reported 2019-2025

Years
2019-2023
Top company
Stryker Corporation

https://glasscript.com/doctor/274414/michael-e-johnson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.